India to Singapore: Digoxin Export Trade Route
India has recorded 60 verified shipments of Digoxin exported to Singapore, representing a combined trade value of $55.0K USD. This corridor is served by 20 active Indian exporters, with an average shipment value of $916 USD. The leading Indian exporter is UNICURE REMEDIES PRIVATE LIMITED, which accounts for 65% of total export value with 10 shipments worth $35.8K USD. On the buying side, ACTIVO INGREDINETS PTE LTD. is the largest importer in Singapore with $25.9K USD in purchases. The top 3 suppliers — UNICURE REMEDIES PRIVATE LIMITED, GENEX PHARMA, LOTUS INTERNATIONAL — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Singapore Digoxin corridor is one of India's established pharmaceutical export routes, with 60 shipments documented worth a combined $55.0K USD. The route is dominated by UNICURE REMEDIES PRIVATE LIMITED, which alone accounts for roughly 65% of all export value, reflecting the consolidated nature of India's digoxin manufacturing sector.
Across 20 active suppliers, the average shipment value stands at $916 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 7 days port-to-port. The route has recorded an annual growth rate of 17.3%, placing it at rank #5 among India's top digoxin export destinations globally.
On the import side, key buyers of Indian digoxin in Singapore include ACTIVO INGREDINETS PTE LTD., TO THE ORDER OF, ACTIVO INGREDINETS PTE LTD and 24 others. ACTIVO INGREDINETS PTE LTD. is the single largest importer with 5 shipments valued at $25.9K USD.
